header logo image


Page 299«..1020..298299300301..310320..»

Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update

November 12th, 2020 11:56 pm

Highlights include closing $19.2 million public offering, uplisting to Nasdaq, and positive progress with multiple candidates currently in Processa’s clinical drug pipeline Highlights include closing $19.2 million public offering, uplisting to Nasdaq, and positive progress with multiple candidates currently in Processa’s clinical drug pipeline

Read more from the original source:
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update

Read More...

PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020

November 12th, 2020 11:56 pm

SPARTA, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard™ delivery system to provide more effective and safer products, VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”™), announced today that the Company has rescheduled its 2020 third quarter financial results call to Monday, November 16, 2020.

View post:
PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020

Read More...

Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights

November 12th, 2020 11:56 pm

WATERTOWN, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today reported business highlights and financial results for the third quarter ended September 30, 2020.

View post:
Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights

Read More...

MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™…

November 12th, 2020 11:56 pm

LA JOLLA, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Principal Investigators Leila Gobejishvili, PhD and Craig McClain, MD at the University of Louisville School of Medicine presented positive results of the in-vitro and in-vivo studies that evaluated MN-001 (tipelukast, referred to as D46 in the presentation) for its anti-liver fibrotic effect in human hepatic stellate cells (HSCs) and in an acute liver injury model at the Liver Meeting Digital Experience™ 2020 (TLMdX™), the annual meeting of the American Association for the Study of Liver Diseases (AASLD).

Read more from the original source:
MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™...

Read More...

BKFC run will preserve the longevity of Paige VanZants MMA career – BJPENN.COM

November 12th, 2020 11:56 pm

According to Bellator middleweight contender Austin Vanderford, former UFC star Paige VanZant intends to return to mixed martial arts in the future.

Vanderford, who is married to VanZant, recently returned to the Bellator cage where he picked up an impressive victory over Vinicius de Jesus. Post-fight, he shed some light on what the future holds for his wife.

VanZant recently parted ways with the UFC, and inked an exclusive, multi-fight deal with BKFC. She is far and away the highest-profile fighter the upstart bare knuckle organization has signed to date.

According to Vanderford, VanZant will be using this time with BKFC to improve her striking for the benefit of her eventual return to MMA.

She felt at this point in her career she needed to make some changes to continue to compete with the top girls, Vanderford told The Telegraph. What shes going to do now will extend the longevity of her career. I know that sounds ironic since shes going to fight in bare knuckle. But shes only 26 and this gives her the opportunity to work on some things. Really work on her striking.

Shes more than likely going to come back to MMA, Vanderford added, shedding some light on what the future holds for VanZant. She wants to try and work on becoming a more well-rounded fighter. Im biased, but in my opinion she will be one of the best in the world.

Paige VanZant closed out her run with the UFC in the summer, when she was submitted by Amanda Ribas in the final bout on her current UFC contract. She then signed with BKFC, but has yet to make her debut with the organization. The former UFCs stars bare knuckle debut was originally expected to go down in November, but is now being targeted for Super Bowl weekend in February.

What do you think the future holds for VanZant?

Read more:
BKFC run will preserve the longevity of Paige VanZants MMA career - BJPENN.COM

Read More...

Seven Ways That Yoga Helps Us As We Age – Longevity LIVE – Longevity LIVE

November 12th, 2020 11:56 pm

It can be easy to believe that yoga is a practice for the young especially as the vast majority of images depicting yoga feature very youthful women engaging in impressive feats of flexibility. However, we do not need gymnastic skills, years of training and fewer than forty candles on the birthday cake to make yoga part of our lives. As a form of exercise and meditative practice, we can embrace yoga at any stage of life, and gain many benefits from doing so.

In recent years, some fantastic yoga practitioners have been working hard to gain representation and depict the true diversity of yoga. Yoga is a broad and adaptable practice that can be used by anyone (whatever their health status, body type, gender, or ethnicity), and it can be particularly helpful as we grow older.

One key factor that separates yoga from other forms of exercise is that in bringing attention to and coordinating the breath with the movement of the body, yoga is a practice in mindfulness. It holistically supports our wellbeing by promoting a mind-body connection and can help us both prevent and ease the symptoms of many common health conditions.

1. Lowering the risk of heart disease

More:
Seven Ways That Yoga Helps Us As We Age - Longevity LIVE - Longevity LIVE

Read More...

How to live longer: Water helps fight off infections, reduce cancer risk and boost longevi – Express

November 12th, 2020 11:56 pm

Every day, the kidneys filter around 120 150 quarts(4800 6000 ounces) of fluid, said Medical News Today.

The health site added: Of these, approximately one to two quarts (40 80 ounces) are removed from the body in the form of urine, and the rest is recovered by the bloodstream.

Water is essential for the kidneys to function and if the kidneys do not function properly, waste products andexcess fluid can build up inside the body.

Untreated,chronic kidney diseasecan lead to kidney failure with the organs not working, and either dialysis or kidney transplantation is required.

Urinary tract infections are the second most common type of infection in the body.

If infections spread to the upper urinary tract, including the kidneys, permanent damage can result. Sudden, or acute, kidney infections can be life-threatening, particularly if septicaemia occurs.

Drinking plenty of water is a simple way to reduce the risk of developing a serious infection.

Excerpt from:
How to live longer: Water helps fight off infections, reduce cancer risk and boost longevi - Express

Read More...

Longevity and Anti-senescence Therapy Market Top Participant To Focus On Regional Expansion the COVID-19 – The Daily Philadelphian

November 12th, 2020 11:56 pm

The global longevity and anti-senescence therapies market should grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.

Report Scope:

The scope of this report is broad and covers various therapies currently under trials in the global longevity and anti-senescence therapy market. The market estimation has been performed with consideration for revenue generation in the forecast years 2018-2023 after the expected availability of products in the market by 2023. The global longevity and anti-senescence therapy market has been segmented by the following therapies: Senolytic drug therapy, Gene therapy, Immunotherapy and Other therapies which includes stem cell-based therapies, etc.

Revenue forecasts from 2028 to 2023 are given for each therapy and application, with estimated values derived from the expected revenue generation in the first year of launch.

The report also includes a discussion of the major players performing research or the potential players across each regional longevity and anti-senescence therapy market. Further, it explains the major drivers and regional dynamics of the global longevity and anti-senescence therapy market and current trends within the industry.

Click Here to Get Sample Premium Report @ https://www.trendsmarketresearch.com/report/sample/11698

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market.

Report Includes:

71 data tables and 40 additional tables An overview of the global longevity and anti-senescence therapy market Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023 Country specific data and analysis for the United States, Canada, Japan, China, India, U.K., France, Germany, Spain, Australia, Middle East and Africa Detailed description of various anti-senescence therapies, such as senolytic drug therapy, gene therapy, immunotherapy and other stem cell therapies, and their influence in slowing down aging or reverse aging process Coverage of various therapeutic drugs, devices and technologies and information on compounds used for the development of anti-ageing therapeutics A look at the clinical trials and expected launch of anti-senescence products Detailed profiles of the market leading companies and potential entrants in the global longevity and anti-senescence therapy market, including AgeX Therapeutics, CohBar Inc., PowerVision Inc., T.A. Sciences and Unity Biotechnology

Summary

Global longevity and anti-senescence therapy market deals in the adoption of different therapies and treatment options used to extend human longevity and lifespan. Human longevity is typically used to describe the length of an individuals lifetime and is sometimes used as a synonym for life expectancy in the demography. Anti-senescence is the process by which cells stop dividing irreversibly and enter a stage of permanent growth arrest, eliminating cell death. Anti-senescence therapy is used in the treatment of senescence induced through unrepaired DNA damage or other cellular stresses.

Global longevity and anti-senescence market will witness rapid growth over the forecast period (2018-2023) owing to an increasing emphasis on Stem Cell Research and an increasing demand for cell-based assays in research and development.

An increasing geriatric population across the globe and a rising awareness of antiaging products among generation Y and later generations are the major factors expected to promote the growth of global longevity and anti-senescence market. Factors such as a surging level of disposable income and increasing advancements in anti-senescence technologies are also providing traction to the global longevity and anti-senescence market growth over the forecast period (2018-2023).

According to the National Institutes of Health (NIH), the total geriatric population across the globe in 2016 was over REDACTED. By 2022, the global geriatric population (65 years and above) is anticipated to reach over REDACTED. An increasing geriatric population across the globe will generate huge growth prospectus to the market.

Senolytics, placenta stem cells and blood transfusions are some of the hot technologies picking up pace in the longevity and anti-anti-senescence market. Companies and start-ups across the globe such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc. are working extensively in this field for the extension of human longevity by focusing on study of genomics, microbiome, bioinformatics and stem cell therapies, etc. These factors are poised to drive market growth over the forecast period.

Global longevity and anti-senescence market is projected to rise at a CAGR of REDACTED during the forecast period of 2018 through 2023. In 2023, total revenues are expected to reach REDACTED, registering REDACTED in growth from REDACTED in 2018.

The report provides analysis based on each market segment including therapies and application. The therapies segment is further sub-segmented into Senolytic drug therapy, Gene therapy, Immunotherapy and Others. Senolytic drug therapy held the largest market revenue share of REDACTED in 2017. By 2023, total revenue from senolytic drug therapy is expected to reach REDACTED. Gene therapy segment is estimated to rise at the highest CAGR of REDACTED till 2023. The fastest growth of the gene therapy segment is due to the Large investments in genomics. For Instance; The National Human Genome Research Institute (U.S.) had a budget grant of REDACTED for REDACTED research projects in 2015, thus increasing funding to REDACTED for approximately REDACTED projects in 2016.

More Info of Impact Covid19 @ https://www.trendsmarketresearch.com/report/covid-19-analysis/11698

Read the original:
Longevity and Anti-senescence Therapy Market Top Participant To Focus On Regional Expansion the COVID-19 - The Daily Philadelphian

Read More...

Revealed: The UK’s Best Off-Grid Getaways – Longevity LIVE – Longevity LIVE

November 12th, 2020 11:56 pm

Lake District

The Lake District is a popular destination for anyone wanting to be at one with nature. The Lake District National Park attracts tourists from across the globe thanks to the spectacular scenery, wildlife, history, and culture on offer. Each year, over 15 million visitors head to the location for a fantastic break away. But surely so many visitors will mean this shouldnt be revered as a go-to off-grid getaway? Wrong! There are still many secluded locations off the beaten track which can satisfy your needs.

Head to Ennerdale Valley and youll be met by nothing but wild beauty. While its not the easiest spot to get to, youll be escaping the crowds and shops and instead be met with an abundance of great walks and cycle tracks. Ennerdale Water is also the most westerly lake in the Lake District, so why not look at the nearby town of Whitehaven for your rural base?

While the Georgian town is continuing to grow in size, it is still one of the 51 Gem Towns in the UK. This title is given to those areas which were considered to be particularly splendid and precious by the Council for British Archaeology in 1964s response to the Traffic in Towns Buchanan Report.

Covid-19 was the cause for the search for Lake District holidays to plummet, but it is beginning to rise once again. For the perfect rural retreat near the Lake District, one of Airbnbs top choices includes a quaint camping pod. Completely off-grid, this accommodation is described as the perfect alternative.

Search rural getaways on Google, and the Peak District is one of the most popular destinations. Known for its picturesque postcard appearance, the Peak District is home to magnificent lakes, reservoirs, and nature reserves. Founded in 1951, it was the first of Britains 15 national parks. Each year, over 13 million visitors descend on the Peak District, with local attractions including Hathersage the reputed grave site of Robin Hood and Tideswell, the 14th century cathedral of the Peak.

Like the Lake District, it is the ideal choice for being at one with nature thanks to its walkways and scenic views. But, while the likes of Buxton is popular with tourists thanks to its range of restaurants and bars, and Matlock has the River Derwent on its doorstep, and there are hidden gems that can help you get a real feel of seclusion on your next off-grid getaway.

While Eyam may be best known for a breakout of the Black Death in 1665, nowadays its a beautifully peaceful village which is home to approximately 1,000 people. Its the typical village that stood still in time and can give you the feel of what life may have been like in yesteryear. With buildings as old as the 9th century, there are many magical stories to pick up on your travels including a visit to the grave of Little John in the local churchyard!

A search on Airbnb unearths many hidden gems of its own, with cottages, a 17th century mill, a woodcutters cabin, and a Mediterranean-style basement flat all gaining rave reviews in the area. All would provide the perfect destination for an off-grid getaway.

With rural areas covering 85 per cent of the UK, but less than one in five of us living there, we are inundated with amazing backdrops for your next off-grid adventure. Do your research fully and bag yourself the perfect location in which to unwind in on your next trip.

*correct as of 1st June 2020

https://www.bbc.co.uk/news/business-52066454

https://www.visitpeakdistrict.com/explore/towns-and-villages

https://www.campsites.co.uk/inspiration/national-parks/secret-places-in-the-lake-district

More here:
Revealed: The UK's Best Off-Grid Getaways - Longevity LIVE - Longevity LIVE

Read More...

Herbstreit doesnt buy into longevity of Texas football in 2020 – Hook’em Headlines

November 12th, 2020 11:56 pm

Texas football is currently locked in a battle with the West Virginia Mountaineers in a critical game at home on Nov. 7. West Virginia and Texas both came into this game with identical records, sitting at 4-2 (3-2 Big 12) a piece. Texas was coming off a nice win last weekend in upset fashion on the road over the previously undefeated and No. 6 ranked Oklahoma State Cowboys in overtime, by the final score of 41-34.

Meanwhile, West Virginia is coming off a nice win of their own from last weekend. West Virginia also took care of business against a ranked Big 12 opponent on Oct. 31, by dominating the previously No. 16 ranked Kansas State Wildcats by the final score of 37-10. Both Texas and West Virginia had momentum trending in the right direction heading into this weekend.

All eyes were on the Longhorns coming into this game to see if head coach Tom Herman can keep his team trending in the right direction and build a three-game winning streak. Texas was just shy of a touchdown favorite ahead of kick off, so they should be able to take care of business against the Mountaineers.

Questions are still being asked about the Longhorns chances to make the Big 12 Championship Game this season. The win over Oklahoma State did restore a lot of hope that Herman can guide the Longhorns to at least earn a spot in the Big 12 Championship Game. They now sit firmly in contention with the likes of the Iowa State Cyclones and Oklahoma schools to get a spot in the Big 12 Title Game.

But ESPNs Kirk Herbstreit found some doubt in the Longhorns chances to make it back to the Big 12 Championship Game for the first time since 2018. Herbstreit projected his conference title game matchup on Nov. 7, saying that it will come down to Iowa State and Oklahoma.

While he did say that he believes Texas will take care of business against West Virginia this weekend, he doesnt believe in this team over the long-term. That does make a lot of sense since the Longhorns were anything but consistent under Hermans direction the last few years.

After the Longhorns take on the Mountaineers, theyre set to face the lowly Kansas Jayhawks on Nov. 21. They have a bye week once the West Virginia game wraps up. The back end of the schedule doesnt look to be as difficult as the front half.

Visit link:
Herbstreit doesnt buy into longevity of Texas football in 2020 - Hook'em Headlines

Read More...

Home Alone Director Chris Columbus: Disney+ Is Wasting Its Time Rebooting the Film – IndieWire

November 12th, 2020 11:56 pm

When Disney acquired Fox for $70 billion, it took full ownership of Fox-owned IP that can now be reimagined, rebooted, and remade under the Mouse House. Enter the upcoming Disney+ streaming series Home Alone, a reboot of director Chris Columbus and producer/writer John Hughes 1990 comedy classic starring Macaulay Culkin, Joe Pesci, Daniel Stern, and Catherine OHara. The film earned over $470 worldwide for Fox and is now getting a Disney spin from Dirty Grandpa director Dan Mazer and a cast that includes Archie Yates, Rob Delaney, and Ellie Kemper.

In a new interview with Insider, Columbus rails against the idea of rebooting his beloved comedy favorite. The director revealed nobody from the Disney+ production got in touch with him about jumpstarting a new Home Alone television franchise not that Columbus thinks a Home Alone reboot is needed.

Its a waste of time as far as Im concerned. Whats the point? Columbus said. Im a firm believer that you dont remake films that have had the longevity of Home Alone. Youre not going to create lightning in a bottle again. Its just not going to happen. So why do it? Its like doing a paint-by-numbers version of a Disney animated film a live-action version of that. Whats the point? Its been done. Do your own thing. Even if you fail miserably, at least you have come up with something original.

RelatedRelated

Before the Disney-Fox merger, the latter studio was developing its own reimagining of Home Alone called Stoned Alone. The plan was for Ryan Reynolds to star in the leading role of an adult stoner who finds himself fending off robbers while alone over the holidays and high on marijuana.

God only knows what that will be, Columbus said. A stoner version of Home Alone? Listen, have fun. I just feel, do something new. Life is short.

The Home Alone reboot cast for Disney+ also includes Kenan Thompson, Ally Maki, and Chris Parnell. Yates, one of the young breakout performers from Taika Waititis Oscar winner Jojo Rabbit, is starring in the child role made famous by Culkin. Disney+s Home Alone reboot had been filming when the industry shut down in March amid the pandemic. No release date has been set.

Sign Up: Stay on top of the latest breaking film and TV news! Sign up for our Email Newsletters here.

Read more from the original source:
Home Alone Director Chris Columbus: Disney+ Is Wasting Its Time Rebooting the Film - IndieWire

Read More...

RPMGlobal looks back on 30 years of XERAS mining software – International Mining

November 12th, 2020 11:56 pm

RPMGlobal is celebrating the longevity of one of the mining industrys most trusted financial budgeting tools, XERAS, which turns 30 this month.

XERAS was first introduced to the mining industry in 1990 in an English desktop format, and within a year or two, had half a dozen users, according to RPM.

RPMGlobal has transformed the XERAS desktop product into a corporate enterprise solution, XERAS Enterprise, which, it says, is regarded as the budgeting solution of choice for many of the worlds top tier mining companies around the globe.

Now operating off a server-orientated database, XERAS Enterprise provides standardised, integrated budgets within a single environment, which enables users across all levels of the organisation to make informed financial decisions.

XERAS Enterprises zero-based budgeting approach delivers true cost control, transparency and financial agility to the budgeting and forecasting process.

Reflecting on 30 years of continuous product investment, RPMGlobal Chief Executive Officer, Richard Mathews, attributed the softwares success to constantly listening, and acting upon, customers evolving needs and challenges.

The uptake of XERAS Enterprise over the years is a testament to the companys commitment to fostering collaborative partnerships with our customers that places their needs at the front and centre of our product innovation strategy, he said.

According Mr Mathews, staying on top of evolving market trends is critical to remaining at the forefront of change.

At RPMGlobal, we are focused on keeping pace with the trends that are shaping the industry, like remote and cloud computing are currently, he said.

When XERAS was first created, for example, most mining operations were run as individual businesses. But that has changed over time.

As organisations have assimilated into larger, multi-site operations, the focus has turned to consistent corporate level solutions and XERAS Enterprise is a key offering in our integrated enterprise suite of products.

RPMGlobals innovative capabilities and ingrained knowledge of the end-to-end mining value chain have helped underpin the continuous improvement process that has led to the re-architecture of XERAS Enterprise throughout its 30-year evolution, it said.

For example, XERAS Enterprise can be integrated into any Enterprise Resource Planning system to deliver a live, zero-based forecasting environment, the company says. This significantly reduces the time it takes to generate budgets and forecasts, delivering companies an accurate financial position at any given time.

Last year marked one of the biggest re-architectural advances for the XERAS products in years with the introduction of XERAS Enterprise 3.0. This release included an updated user experience, improved database technology and enhanced enterprise capabilities.

Mathews said the company remained proud of the continued modernisation of the financial modelling software, which has helped ensure its longevity in the market.

XERAS Enterprise is a true 21st century software offering that provides trust in the numbers by standardising processes and removing manual data entry, while also allowing for agility and scalability that isnt available in any other system, he said.

Future step-changes in the offering will continue to be driven by customer engagement which involves understanding the clients usage and requirements and finding solutions that can best fulfil those needs.

The rest is here:
RPMGlobal looks back on 30 years of XERAS mining software - International Mining

Read More...

Women’s health and wealth: how to plan ahead | MyWalletHero – Motley Fool UK

November 12th, 2020 11:56 pm

Image source: Getty Images

Share this page:

Although the latest figures show that the growth of life expectancy is slowing, women are living longer than ever. That is, of course, a great thing. But what are the implications of womens health and longevity when it comes to planning for retirement?

The latest Office for National Statistics (ONS) figures show that the average life expectancy for women is 83.1 years. This is undoubtedly positive in terms of enjoying life, friends and family, but it also means our pensions need to last longer.

But research shows that women typically retire with pensions worth just a fraction of mens. The reasons are, of course, varied, but it often comes down to issues like maternity leave, career breaks to care for family and being in lower paid jobs to start with.

But regardless of the whys and wherefores, the effect on our finances can be detrimental to say the least.

Talking about the link between womens health and financial outlook, Sharon Bonfield, Commercial Research Specialist at St Jamess Place Wealth Management, says:

Women typically live longer than men and may have a smaller pension pot, they need to plan accordingly to make their money last. While longevity sounds like a blessing, we wouldnt want to be unwell and struggling financially during our later-life years. But many women run the risk that this will be their future. A 40-year-old woman has a one in four chance of living to age 96, and a one in ten chance of living to 100.

Women not only need their pensions to last longer, they also generally have smaller pension pots to use during these extra years of life. We already know that women typically retire with one-fifth of the pension wealth of men. New analysis from the Centre for Economics and Business Research found that, when life expectancy is taken into account, the gender pensions gap could be as much as 108,130 for single women, and 186,120 for women who are married or in a relationship.

What you need depends on your lifestyle. To get an idea of whats enough, the Retirement Living Standards were developed. Based on independent research by Loughborough University, the standards suggest the amount we might need based on levels of comfort. The figures below are for singles not in a relationship.

Retirement Living Standards suggests singles will need at least 10,200 a year to live on. If they live in London, this goes up to 12,400.

This should work out enough to cover household bills, including DIY and maintenance. It also allows for a modest weekly shop (38), holidaying in the UK and enough for clothes, shoes and gifts. Crucially, it doesnt include maintaining a car, which for many singles can be a necessity.

The forecast here is 20,200 per year, or 24,100 in London. This allows for an increased budget in all areas and includes two weeks worth of European holidays. It also includes a 3-year-old car.

To live comfortably, the estimate is 33,000, going up to 36,300 in London. This level of annual income provides much greater freedom and a lot more comfort. It allows for a new kitchen and bathroom every 10-15 years and 3 weeks in Europe. Theres also enough for a newer car which can be replaced every five years.

If these figures have left you feeling a little discouraged, dont fret. There are things you can do right now to ensure a stress-free retirement. Sharon Bonfield offers this reassurance:

Luckily, there are things all women can do to increase your chances of a financially secure life, however long you live. If you do nothing else, have a think about what you want your future to look like. Do an appraisal of all your long-term savings plans, rounding up any small savings pots you may have forgotten about over time. Sit down and have a chat with a financial adviser to see how things are actually looking for your retirement years.

The most important thing is to not bury your head in the sand. After all, womens health and longevity should always be viewed positively rather than as a financial albatross.

The first step is to do your homework, which could mean getting to grips with understanding how pensions work in the first place and what you might already have. And as Sharon advises, think about what you want your future to look like. For example, have you considered early retirement?

Finally, professional help is always a wise investment, but its important to seek the right help. Our guide can point you in the right direction when it comes to choosing a financial advisor.

If youre looking for more ways to make your money work for you, why not sign up for MyWalletHeros email newsletter? Youll receive our teams top money-saving tips, lifestyle hacks and handy personal finance must-knows delivered straight to your inbox

Just enter your email address below to sign up now:

Some offers on MyWalletHero are from our partners its how we make money and keep this site going. But does that impact our ratings? Nope. Our commitment is to you. If a product isnt any good, our rating will reflect that, or we wont list it at all. Also, while we aim to feature the best products available, we do not review every product on the market. Learn more here. The statements above are TheMotleyFools alone and have not been provided or endorsed by bank advertisers. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of TheMotleyFools board of directors. TheMotleyFool UK has recommended Barclays, Hargreaves Lansdown, HSBC Holdings, Lloyds Banking Group, Mastercard, and Tesco.

Follow this link:
Women's health and wealth: how to plan ahead | MyWalletHero - Motley Fool UK

Read More...

Chris Long, Entrepreneur, Athlete, Coach, and Author, Shares His Story of Adversity, and the Resilience and Support That Unlocked His Full Potential -…

November 12th, 2020 11:56 pm

ORANGE, CA / ACCESSWIRE / November 9, 2020 / Just a few years ago Chris Long was broken.

He had just endured one of the most difficult seasons of his life and was battling intense anxiety and depression. He felt completely lost, but he was determined to not give up. In his darkest hour, Chris tapped into an inner strength he'd forgotten he had.

Born and raised in Orange, California, Chris was the son of two hardworking and successful parents. He is no stranger to adversity, tragedy, and loss.At just 6 years old, Chris lost his half brother in a tragic motorcycle accident, leaving him an only child. This event not only shifted the dynamics of his family, but also increased the pressure he felt to make his parents proud. He grew up playing any sport he could and soon realized a passion and affinity for football. He captained the Santa Margarita football team to a CIF state victory and went on to play football at the University of San Diego, where he received numerous awards, played in and or started every single game as a USD Torero, and was nominated to the Academic-All-American award multiple times as a result of his in-season GPAs. Although he'd obtained his degree in Business, Chris couldn't shake his love for fitness and the science behind motivating people to be their best. He spent the next 15 years working in the corporate fitness industry for 24 Hour Fitness, Equinox, Nike, and Velocity.

Still, Chris felt as though he was missing something. When layoffs in the big box gym industry took place in 2015, Chris was sent home with his final check from the company that he was proud to work for and treated as if it were his own, often investing his own finances to pay for certifications for his fellow employees.

Chris Long turns it on when the pressure is on and he definitely did at this point. Left unemployed, he decided to pursue his lifelong dream of opening a fitness and training studio. He opened the doors of Longevity soon thereafter. Longevity has had great success and even despite an early stage growth tactic that Chris rolled the dice on, the Longevity brand has never been stronger and has enriched the lives of so many. Working with both young athletes, and adults, to date, Chris has trained 80+ young athletes to succeed in collegiate athletics and has also helped 13 people lose over 100 lbs through his program. Chris has created and sustained strong relationships with a few of the athletes that he trained early on who he plans to make ambassadors once they graduate in order to scale Longevity in the future.

Story continues

"I run a tight ship," says Long, "Our expectations inspire people to level up in all aspects of their life in order to create habits that stick. We use a formula that sets people up for success. We provide the tools and the platform to improve their life and performance. This builds self confidence, on the path towards fulfilling one's true potential."

Chris keeps five key components of health in mind when working with each individual: Mindset, Nutrition, Sleep, Training, and Recovery.

"We ask that each member and client gives their 110% because we are always going to give the same in return!"

Chris has had both extreme success and some very difficult lessons. Unfortunately, most people don't share the difficulty involved with starting a business. While start-ups are often glamorized and praised for their success, Chris shares that there is a rougher side to entrepreneurship.

"It is lonely and there are sleepless nights, overdue bills at times. I would deal with debilitating anxiety leaving me reeling."

It was at this breaking point that Chris realized he needed to alter his mindset and seek support if he wanted to see his business succeed. He knew he needed some guidance because he had plateaued a bit and began sputtering as he was trying to get his company off of the ground.

He knew he had something special with Longevity and he knew he had all the talent in the world but he needed confirmation from someone he respected in the sports industry, maybe some words of affirmation. Chris then turned to a close family friend Leigh Steinberg of Steinberg Sports and Entertainment and asked for an hour of his time. Leigh, being his generous self, gave Chris his entire afternoon. Chris walked out knowing what he wanted as Leigh gave Chris confirmation that he has all it takes to accomplish anything. Chris and Leigh discussed strategy and alignment, the blocking and tackling of business. The meeting was extremely productive and Chris then reached out to Mr. David Metzler who is the CEO of Sports One Marketing, Warren Moon's marketing agency. David ran Leigh Steinberg's company for several years and represented some of the world's greatest athletes.

Simultaneously, Chris began to prioritize his health and self-love as his number one focus.

"If we don't have our health, we have nothing."

Chris endured quite a bit of pain early on in his business venture and that came as a result of hard life lessons, but he pulled himself up by his bootstraps, and asked for help from a world renowned mentor. This help came in the form of David Meltzer, his business coach and mentor. Metlzer has worked with Chris to create a clear vision for his life and his business. He taught him the value of radical humility and the importance of shining light in an otherwise dark world.

"Trauma corrodes our personal light, we have to work through that trauma before we can shine," says Chris. "Sometimes we simply need that one guy to believe in us. For me that was Coach D (as I call him). From our first conversation David helped me regain my positive spirit and loving, welcoming nature."

Long claims after a divorce rocked his world, he had trouble viewing the world in a positive light. Meltzer was able to refocus Chris and his framework leading to helping him view the world through a lens of gratitude every single day no matter what the circumstance. Chris has always possessed discipline but he worked on building a routine where he practices ending fear every single morning at 3:45 am during his morning meditation prior to seeing his first clients of the day at 4:45 am.

Armed with renewed confidence, Chris sought additional support for his business and it couldn't have come at a better time. When he needed more coaches at Longevity, he turned to one of the best coaches he knew and had the privilege to play for, Coach John Rodriguez, his old football coach at Santa Margarita that he played for between 1993-1997. Chris counts himself incredibly blessed to have been able to provide value to the same man that had poured into him all those years ago.

"Coach J-Rod is like a big brother to me. He mentored me early on in my life and I have always wanted to find a way to give back to those who have helped me throughout the years, there is nobody more deserving of an opportunity to grow a startup to its potential than Coach J-Rod."

Within a few months, Chris was ready to bring on an additional business advisor, Robert Toler. Robert played football at the University of Colorado and is a star athlete. The apple doesn't fall far from the tree either, Robert's youngest daughter, Saleh, is a track athlete at Los ALamitos High school, his eldest daughter ran and coached track in college, and his son Titus, who was highly recruited in high school out of St John Bosco, is a defensive back at the University of Wisconsin.

As Chris puts it, "Robert has the skillset to do pretty much anything with this company. We are both in similar stages in our lives and both strong in our faith. The day he walked into my facility, I instantly knew we would work together. I never wanted to grow this on my own. My wife started training his daughter and it just seemed right. We met several times and I talked about the vision I have had from day 1 which was to scale the business."

Chris already respected Robert, as his longtime teammate and ex NFL Texas Texan Jon Minardi played in high school with him. Robert brought innovative business strategy and growth development structural techniques to Longevity.

Chris states, "Robert is a very organized person. I am a very passionate people' person. That combo is so synergistic and pivotal to the growth of Longevity. I needed someone with thick skin and who I know would not take shortcuts."

Chris also works with a trainer himself to help him with his own athleticism and flexibility, a professional dancer named Sarah Gertler. She has also played a role in the success of Longevity.

Finally, Chris' wife, Lety Long, has proven to be a pivotal source of support for him during his darkest hours. Her positivity and wisdom encouraged him to persevere through the highs and lows of owning a business.

"Lety and I have a special relationship, I respect her more than any human being on the planet. There is just so much goodness that comes from Lety, and she has helped me build this company from the ground up," says Chris.

Lety coaches at Longevity part time outside of her regular career as a 7-8th grade special needs teacher at Kraemer Middle School.

Chris credits each of these unique individual's support and impact as the key component to the company elevating. Longevity's success through a season in which many other businesses were forced to close their doors has proven that one man is only capable of so much, but when you have a team of great leaders, amazing things can happen.

Chris is so very grateful for his members as they invest in themselves and work hard to better themselves by following the Longevity formula.

"Without them, there is no Longevity. These members have become family to me, it is pretty special."

"The past five years have flown by,'' Chris says.

When Chris Long started his business, he was a broken man. But through the support of those around him and his quest for self-love, he has conquered the impossible. Today, Chris feels fortunate for the years of suffering he endured, as they served to instill in him a radical humility and allowed him to see the world, and those around him, with renewed gratitude.

Chris shares the mantra that carried him through that difficult season, and now provides daily inspiration, "Live with radical humility, learn with authentic grace, and lead with extreme gratitude."

Chris is dedicated to bringing this same vision to the lives of others through personal and group training/coaching and his new book, The Longevity Redemption, available for pre-order. The book provides a first hand look into the tools Chris utilized to overcome depression and live into his full potential. Over the last few years, Chris has regained his confidence and learned to love himself again, and this is the same gift he strives to bring to each of his clients and readers.

Chris concludes, "As a coach, it is my mission to give people the confidence to believe in themselves. Once you have that confidence, you will do what you can do. You can do what you must do."

Contact Name: Chris LongBusiness Name: Longevity Sport and FitnessAddress: 966 N. Elm St. Orange, CA 92867Phone Number: (949) 350-2077Website Link: https://www.cplongevity.com/Send Email

SOURCE: Chris Long

View source version on accesswire.com: https://www.accesswire.com/615321/Chris-Long-Entrepreneur-Athlete-Coach-and-Author-Shares-His-Story-of-Adversity-and-the-Resilience-and-Support-That-Unlocked-His-Full-Potential

Excerpt from:
Chris Long, Entrepreneur, Athlete, Coach, and Author, Shares His Story of Adversity, and the Resilience and Support That Unlocked His Full Potential -...

Read More...

Katharine the great white shark resurfaces off East Coast | TheHill – The Hill

November 12th, 2020 11:56 pm

A self-described "misunderstood but sassy girl just tryin' to get some fish, Katharine the great white shark has resurfaced after more than a year. What was she doing? Well, just tryin to get some fish.

I mean. I was chasing a fish, but Ill roll with it. #WhatHeSaid https://t.co/NVoXsmQPi9

With more than 64,000 followers on Twitter, Katharine qualifies as an A-lister in the white shark community so obviously, she doesnt run her own social media account. She has people for that.

READ MORE LIKE THIS FROM CHANGING AMERICA

WILDLIFE GROUPS CHALLENGE TRUMP ADMINISTRATION ON GRAY WOLF DELISTING

THERES AT LEAST ONE GROUP 2020 WAS GOOD FOR: GREAT WHITE SHARKS

NATIONAL PARK SERVICE ALLOWS FOR THE KILLING OF NATIVE ELK TO APPEASE RANCHERS, ANGERING CONSERVATIONISTS

CRY LEVIATHAN: A WARNING FROM THE WORLDS WHALES

Rob Landers is a journalist and actor who runs the account on behalf of OCEARCH, a nonprofit data collection organization that among other things tracks a number of white sharks around the world. White sharks are especially notorious for going radio silent (the radio being a SPOT-tag attached to their dorsal fin), and Katharine was last seen in May 2019.

According to the OSEARCH online tracking map, the 2,300-pound young adult popped up on their radar on Oct. 30 at 8:27 p.m. in the Atlantic Ocean, east of Virginia, after last being spotted near South Carolina.

America is changing faster than ever! Add Changing America to your Facebook or Twitter feed to stay on top of the news.

OCEARCH first tagged Katharine off the coast of Massachusettsin 2013 and has been following her ever since, setting a record for the longevity of her transmitter, Bryan Franks of Jacksonville University said on Facebook.

She was named for Katharine Lee Bates, a Cape Cod native and songwriter who wrote "America the Beautiful, and fans noted that she resurfaced just in time for the presidential elections, with the tweet "Miss Me?"

Safe to come up again? Yall are having a crazy week up there. #sharkgirl #sharkworld

It's been a pretty good year for Atlantic white sharks, all things considered, and a record number were recently tagged off the coast of southern California. Still, they are considered a vulnerable species, according to the World Wildlife Fund, thanks to years of human hunting and accidents. The world's largest known predatory fish often concentrate in warm waters near coasts, where there is an abundance of fish and marine mammals for them to prey on, making them susceptible to human interaction.

WHAT YOU NEED TO KNOW ABOUT CLIMATE CHANGE RIGHT NOW

THE GREENLAND ICE SHEET IS MELTING TO A POINT OF NO RETURN: STUDY

WHY ITS NOW COOL TO EAT UNPOPULAR FISH

A RECORD-BREAKING HEAT WAVE CHANGED ANTARCTICA IN 9 DAYS

SUMMERS ARE GETTING HOTTER. WHEN WILL IT GET TOO HOT TO WORK IN?

SAVING THE ARCTIC: THE WISDOM OF THE INUIT AND THE FUTURE OF THE NORTH POLE

Read this article:
Katharine the great white shark resurfaces off East Coast | TheHill - The Hill

Read More...

The Amniotic Fluid Stem Cell Therapy market to be in conjunction to growth from 2018 to 2026 – PRnews Leader

November 11th, 2020 11:56 am

Stem cells are biological cells which have the ability to distinguish into specialized cells, which are capable of cell division through mitosis. Amniotic fluid stem cells are a collective mixture of stem cells obtained from amniotic tissues and fluid. Amniotic fluid is clear, slightly yellowish liquid which surrounds the fetus during pregnancy and is discarded as medical waste during caesarean section deliveries. Amniotic fluid is a source of valuable biological material which includes stem cells which can be potentially used in cell therapy and regenerative therapies. Amniotic fluid stem cells can be developed into a different type of tissues such as cartilage, skin, cardiac nerves, bone, and muscles. Amniotic fluid stem cells are able to find the damaged joint caused by rheumatoid arthritis and differentiate tissues which are damaged.

For more insights into the Market, request a sample of this report @https://www.persistencemarketresearch.com/samples/23101

Medical conditions where no drug is able to lessen the symptoms and begin the healing process are the major target for amniotic fluid stem cell therapy. Amniotic fluid stem cells therapy is a solution to those patients who do not want to undergo surgery. Amniotic fluid has a high concentration of stem cells, cytokines, proteins and other important components. Amniotic fluid stem cell therapy is safe and effective treatment which contain growth factor helps to stimulate tissue growth, naturally reduce inflammation. Amniotic fluid also contains hyaluronic acid which acts as a lubricant and promotes cartilage growth.

With increasing technological advancement in the healthcare, amniotic fluid stem cell therapy has more advantage over the other therapy. Amniotic fluid stem cell therapy eliminates the chances of surgery and organs are regenerated, without causing any damage. These are some of the factors driving the growth of amniotic fluid stem cell therapy market over the forecast period. Increasing prevalence of chronic diseases which can be treated with the amniotic fluid stem cell therapy propel the market growth for amniotic fluid stem cell therapy, globally. Increasing funding by the government in research and development of stem cell therapy may drive the amniotic fluid stem cell therapy market growth. But, high procedure cost, difficulties in collecting the amniotic fluid and lack of reimbursement policies hinder the growth of amniotic fluid stem cell therapy market.

For Information On The Research Methodology request here @https://www.persistencemarketresearch.com/methodology/23101

The global amniotic fluid stem cell therapy market is segmented on basis of treatment, application, end user and geography:

To receive extensive list of important regions, Request TOC here @https://www.persistencemarketresearch.com/toc/23101

Rapid technological advancement in healthcare, and favorable results of the amniotic fluid stem cells therapy will increase the market for amniotic fluid stem cell therapy over the forecast period. Increasing public-private investment for stem cells in managing disease and improving healthcare infrastructure are expected to propel the growth of the amniotic fluid stem cell therapy market.

However, on the basis of geography, global Amniotic Fluid Stem Cell Therapy Market is segmented into six key regionsviz. North America, Latin America, Europe, Asia Pacific Excluding China, China and Middle East & Africa. North America captured the largest shares in global Amniotic Fluid Stem Cell Therapy Market and is projected to continue over the forecast period owing to technological advancement in the healthcare and growing awareness among the population towards the new research and development in the stem cell therapy. Europe is expected to account for the second largest revenue share in the amniotic fluid stem cell therapy market. The Asia Pacific is anticipated to have rapid growth in near future owing to increasing healthcare set up and improving healthcare expenditure. Latin America and the Middle East and Africa account for slow growth in the market of amniotic fluid stem cell therapy due to lack of medical facilities and technical knowledge.

Some of the key players operating in global amniotic fluid stem cell therapy market are Stem Shot, Provia Laboratories LLC, Thermo Fisher Scientific Inc. Mesoblast Ltd., Roslin Cells, Regeneus Ltd. etc. among others.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

Read the original post:
The Amniotic Fluid Stem Cell Therapy market to be in conjunction to growth from 2018 to 2026 - PRnews Leader

Read More...

The Canine Stem Cell Therapy Market To Move Away From Insipidness, Reach US$ 218.2 Mn – PRnews Leader

November 11th, 2020 11:56 am

Market Report Summary

For Full Information -> Click Here

Read Full Press Release Below

Persistence Market Research (PMR) has published a new research report on canine stem cell therapy. The report has been titled, Canine Stem Cell Therapy Market: Global Industry Analysis 2016 and Forecast 20172026.Veterinary research has been used in regenerative and adult stem cell therapy andhas gained significant traction over the last decade.

Canine stem cell therapy products are identified to have gained prominence over the past five years, and according to the aforementioned research report, the market for canine stem cell therapy will expand at a moderate pace over the next few years.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/15550

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/15550

Though all animal stem cells are not approved by FDA, veterinary stem-cell manufacturers and university researchers have been adopting various strategies in order to meet regulatory approvals, and streamline and expedite the review-and-approval process. The vendors in the market are incessantly concentrating on research and development to come up with advanced therapy, in addition to acquiring patents.

In September 2017, VetStem Biopharma, Inc. received European patent granted to the University of Pittsburgh and VetStem received full license of the patent then. This patent will eventually provide the coverage for the ongoing commercial and product development programs of VetStem and might be also available for licensing to other companies who are rather interested in this field.

The other companies operating in the global market for canine stem cell therapy are VETherapy Corporation, Aratana Therapeutics, Inc., Regeneus Ltd, Magellan Stem Cells, Animal Cell Therapies, Inc., and Medrego, among others.

According to the Persistence Market Research report, the globalcanine stem cell therapy marketis expected to witness a CAGR of 4.2% during the forecast period 2017-2026. In 2017, the market was valued at US$ 151.4 Mn and is expected to rise to a valuation of US$ 218.2 Mn by the end of 2026.

Burgeoning Prevalence of Chronic Diseases in Dogs to Benefit Market

Adipose Stem Cells (ASCs) are the most prevalent and in-demand adult stem cells owing to their safety profile, ease of harvest, and use and the ability to distinguish into multiple cell lineages. Most early clinical research is focused on adipose stem cells to treat various chronic diseases such as arthritis, tendonitis, lameness, and atopic dermatitis in dogs.

A large area of focus in veterinary medicine is treatment of osteoarthritis in dogs, which becomes more prevalent with age. Globally, more than 20% dogs are suffering from arthritis, which is a common form of canine joint and musculoskeletal disease. Out of those 20%, merely 5% seem to receive the treatment.

However, elbow dysplasia in canine registered a prevalence rate of 64%, converting it into an alarming disease condition to be treated on priority. Thereby, with the growing chronic disorders in canine, the demand for stem cell therapy is increasing at a significant pace.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15550

Expensive Nature of Therapy to Obstruct Growth Trajectory

Expensive nature and limited access to canine stem cell therapy has demonstrated to be a chief hindrance forestalling its widespread adoption. The average tier II and tier III veterinary hospitals lack the facilities and expertise to perform stem cell procedures, which necessitates the referral to a specialty vet hospital with expertise veterinarians.

A trained veterinary physician charges high treatment cost associated with stem cell therapy for dogs. Generally, dog owners have pet insurance that typically covers maximum cost associated with steam cell therapy to treat the initial injury but for the succeeding measures in case of retreatment, the costs are not covered under the pet insurance. The stem cell therapy is thus cost-prohibitive for a large number of pet owners, which highlights a major restraint to the market growth. Stem cell therapy is still in its developmental stage and a positive growth outcome for the market cannot be confirmed yet.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website https://www.persistencemarketresearch.com

Read more:
The Canine Stem Cell Therapy Market To Move Away From Insipidness, Reach US$ 218.2 Mn - PRnews Leader

Read More...

Latest Update 2020: Why Dynamics of Stem Cell Therapy Market Is Changing Drastically? What If History Is Any Guide? – Eurowire

November 11th, 2020 11:56 am

The global stem cell therapy market is estimated to surpass $18,391.9 million by 2027, exhibiting a CAGR of 10.0% from 2020 to 2027.

The report aims to offer a clear picture of the current scenario and future growth of the global Stem Cell Therapy market. The report provides scrupulous analysis of global market by thoroughly reviewing several factors of the market such as vital segments, regional market condition, market dynamics, investment suitability, and key players operating in the market. Besides, the report delivers sharp insights into present and forthcoming trends & developments in the global market.

The report articulates the key opportunities and factors propelling the global Stem Cell Therapy market growth. Also, threats and limitations that have the possibility to hamper the market growth are outlined in the report. Further, Porters five forces analysis that explains the bargaining power of suppliers and consumers, competitive landscape, and development of substitutes in the market is also sketched in the report.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/527

The report reveals various statistics such as predicted market size and forecast by analyzing the major factors and by assessing each segment of the global Stem Cell Therapy market. Regional market analysis of these segments is also provided in the report. The report segments the global market into four main regions including Asia-Pacific, Europe, North America, and LAMEA. Moreover, these regions are sub-divided to offer an exhaustive landscape of the Stem Cell Therapy market across key countries in respective regions. Furthermore, the report divulges some of the latest advances, trends, and upcoming opportunities in every region.

Furthermore, the report profiles top players active in the global Stem Cell Therapy market. A comprehensive summary of 10 foremost players operating in the global market is delivered in the report to comprehend their position and footmark in the industry. The report highlights various data points such as short summary of the company, companys financial status and proceeds, chief company executives, key business strategies executed by company, initiatives undertaken & advanced developments by the company to thrust their position and grasp a significant position in the market.

RESEARCH METHODOLOGY

The research report is formed by collating different statistics and information concerning the Stem Cell Therapy market. Long hours of deliberations and interviews have been performed with a group of investors and stakeholders, including upstream and downstream members. Primary research is the main part of the research efforts; however, it is reasonably supported by all-encompassing secondary research. Numerous product type literatures, company annual reports, market publications, and other such relevant documents of the leading market players have been studied, for better & broader understanding of market penetration. Furthermore, medical journals, trustworthy industry newsletters, government websites, and trade associations publications have also been evaluated for extracting vital industry insights.

Connect with Our Analyst to Contextualize Our Insights for Your Business:https://www.researchdive.com/connect-to-analyst/527

KEY MARKET BENEFITS

KEY MARKET SEGMENTS

The global Stem Cell Therapy market is segmented on the basis of the following:

Global Stem Cell Therapy Market By Product Type:

Global Stem Cell Therapy Market By Applications:

Global Stem Cell Therapy Market By Regions:

Top Leading key players stated in Global Stem Cell Therapy Market report are:

Astellas Pharma Inc., Capricor Therapeutics, Cellectis, Cellular Dynamics, Celyad, CESCA Therapeutic, DiscGenics, Gamida Cell, Mesoblast Ltd, Novadip Biosciences, OxStem.

The report also summarizes other important aspects including financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments of the leading players.

Contact Us:

Mr. Abhishek PaliwalResearch Dive30 Wall St. 8th Floor, New YorkNY 10005 (P)+ 91 (788) 802-9103 (India)+1 (917) 444-1262 (US) TollFree : +1 -888-961-4454Email:[emailprotected]LinkedIn:https://www.linkedin.com/company/research-diveTwitter:https://twitter.com/ResearchDiveFacebook:https://www.facebook.com/Research-DiveBlog:https://www.researchdive.com/blogFollow us on:https://covid-19-market-insights.blogspot.com

Go here to read the rest:
Latest Update 2020: Why Dynamics of Stem Cell Therapy Market Is Changing Drastically? What If History Is Any Guide? - Eurowire

Read More...

Trending News: Stem Cell Therapy Market Anticipated for Progressive CAGR Growth During 2020-2027 – The Think Curiouser

November 11th, 2020 11:56 am

The global stem cell therapy market is estimated to surpass $18,391.9 million by 2027, exhibiting a CAGR of 10.0% from 2020 to 2027.

The report aims to offer a clear picture of the current scenario and future growth of the global Stem Cell Therapy market. The report provides scrupulous analysis of global market by thoroughly reviewing several factors of the market such as vital segments, regional market condition, market dynamics, investment suitability, and key players operating in the market. Besides, the report delivers sharp insights into present and forthcoming trends & developments in the global market.

The report articulates the key opportunities and factors propelling the global Stem Cell Therapy market growth. Also, threats and limitations that have the possibility to hamper the market growth are outlined in the report. Further, Porters five forces analysis that explains the bargaining power of suppliers and consumers, competitive landscape, and development of substitutes in the market is also sketched in the report.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/527

The report reveals various statistics such as predicted market size and forecast by analyzing the major factors and by assessing each segment of the global Stem Cell Therapy market. Regional market analysis of these segments is also provided in the report. The report segments the global market into four main regions including Asia-Pacific, Europe, North America, and LAMEA. Moreover, these regions are sub-divided to offer an exhaustive landscape of the Stem Cell Therapy market across key countries in respective regions. Furthermore, the report divulges some of the latest advances, trends, and upcoming opportunities in every region.

Furthermore, the report profiles top players active in the global Stem Cell Therapy market. A comprehensive summary of 10 foremost players operating in the global market is delivered in the report to comprehend their position and footmark in the industry. The report highlights various data points such as short summary of the company, companys financial status and proceeds, chief company executives, key business strategies executed by company, initiatives undertaken & advanced developments by the company to thrust their position and grasp a significant position in the market.

RESEARCH METHODOLOGY

The research report is formed by collating different statistics and information concerning the Stem Cell Therapy market. Long hours of deliberations and interviews have been performed with a group of investors and stakeholders, including upstream and downstream members. Primary research is the main part of the research efforts; however, it is reasonably supported by all-encompassing secondary research. Numerous product type literatures, company annual reports, market publications, and other such relevant documents of the leading market players have been studied, for better & broader understanding of market penetration. Furthermore, medical journals, trustworthy industry newsletters, government websites, and trade associations publications have also been evaluated for extracting vital industry insights.

Connect with Our Analyst to Contextualize Our Insights for Your Business:https://www.researchdive.com/connect-to-analyst/527

KEY MARKET BENEFITS

KEY MARKET SEGMENTS

The global Stem Cell Therapy market is segmented on the basis of the following:

Global Stem Cell Therapy Market By Product Type:

Global Stem Cell Therapy Market By Applications:

Global Stem Cell Therapy Market By Regions:

Top Leading key players stated in Global Stem Cell Therapy Market report are:

Astellas Pharma Inc., Capricor Therapeutics, Cellectis, Cellular Dynamics, Celyad, CESCA Therapeutic, DiscGenics, Gamida Cell, Mesoblast Ltd, Novadip Biosciences, OxStem.

The report also summarizes other important aspects including financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments of the leading players.

Contact Us:

Mr. Abhishek PaliwalResearch Dive30 Wall St. 8th Floor, New YorkNY 10005 (P)+ 91 (788) 802-9103 (India)+1 (917) 444-1262 (US) TollFree : +1 -888-961-4454Email:[emailprotected]LinkedIn:https://www.linkedin.com/company/research-diveTwitter:https://twitter.com/ResearchDiveFacebook:https://www.facebook.com/Research-DiveBlog:https://www.researchdive.com/blogFollow us on:https://covid-19-market-insights.blogspot.com

The rest is here:
Trending News: Stem Cell Therapy Market Anticipated for Progressive CAGR Growth During 2020-2027 - The Think Curiouser

Read More...

Stem cells key to ALS therapy – Agoura Hills Acorn

November 11th, 2020 11:55 am

By The Acorn Staff | on November 05, 2020

Twenty years ago, when stem cell therapy was highly regulated in the United States and other countries, it was well underway in the Hadassah Hospital labs in Jerusalem.

Never would we have imagined that the U.S. expansion of one of the key clinical trials conducted in our labs in Israel would be later funded by Californias Stem Cell Institute.

In 2004, California had the foresight to advance this critical area of research with the passage of Prop. 71 in 2004.

Stem cells replace damaged or diseased tissue. In this way, treatments or cures for diseases like age-related macular degeneration, ALS, MS, Parkinsons, Alzheimers and diabetes could be a reality in the foreseeable future.

I come to this subject from a place of personal sorrow. I watched my father-in-law, Irv, suffer for 12 years with ALS, a man I loved as if he were my own father. He fought hard. He made every minute of his battle meaningful, to soak up as much life as he could until he couldnt.

Hadassah researchers conducted the worlds first clinical trial using the patients own bone marrow stem cells to treat ALS. Expanded stem cell trials are now taking place here in California to treat ALS.

The California Stem Cell Agencys ALS funding has awarded a total of $79 million in grants to understand ALS and then to translate those discoveries into treatments and therapies. Two have already reached the clinical trial phase.

A Phase 1 clinical trial at Cedars-Sinai was funded to investigate the safety and efficacy of ways in which surviving neurons can be protected in people with ALS.

The second, a Phase 3 clinical trial at Brainstorm Cell Therapeutics, first began in Israel. The approach is to use mesenchymal stem cells derived from bone marrow boosted with protective factors to support and protect the neurons of ALS patients.

Stacey DorenfeldAgoura Hills

Dorenfeld is the National State Advocacy co-chair and the Hadassah Southern California advocacy chair.

Go here to read the rest:
Stem cells key to ALS therapy - Agoura Hills Acorn

Read More...

Page 299«..1020..298299300301..310320..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick